Spectrum Pharmaceuticals Inc. | Mutual Funds
Mutual Funds that own Spectrum Pharmaceuticals Inc.
PRIMECAP Odyssey Aggressive Growth Fund
9,730,000
9.35%
5,426,800
1.86%
06/30/2018
iShares Core S&P Small Cap ETF
5,164,623
4.96%
1,461
0.23%
09/06/2018
SPDR S&P Biotech ETF
3,011,528
2.89%
7,749
1.11%
09/06/2018
Fidelity Select Biotechnology Portfolio
2,407,471
2.31%
-782,146
0.56%
07/31/2018
Vanguard Small Cap Index Fund
2,355,223
2.25%
30,457
0.05%
07/31/2018
Vanguard Total Stock Market Index Fund
2,353,086
2.25%
0
0.01%
07/31/2018
iShares Russell 2000 ETF
2,092,240
2%
-1,116
0.09%
09/06/2018
Vanguard Small Cap Growth Index Fund
1,346,417
1.29%
22,284
0.11%
07/31/2018
Vanguard Extended Market Index Fund
1,238,735
1.19%
33,958
0.04%
07/31/2018
iShares Nasdaq Biotechnology ETF
1,201,989
1.15%
-15,708
0.26%
09/06/2018
| Address |
11500 South Eastern Avenue
Henderson Nevada 89052
United States
|
|
Employees
|
- |
| Website |
http://www.sppirx.com |
| Updated |
07/08/2019 |
| Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development, and commercialization of pipeline of late-stage clinical and commercial products. It operates through the following brands: FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ, and EVOMELA. The company was founded in December 1987 and is headquartered in Henderson, NV. |
